Wildcat Capital Management LLC bought a new position in shares of Silexion Therapeutics Corp (NASDAQ:SLXN – Free Report) during the third quarter, according to its most recent filing with the ...

Silexion Therapeutics (SLXN) announced it has completed an expanded development plan for its next-generation siRNA candidate, SIL204, which the ...

Silexion Therapeutics announces an expanded development plan for SIL204, targeting KRAS-driven cancers, to be presented at the NeauxCancer 2025 Conference. Silexion Therapeutics Corp., a ...

Pre-Market: 4:32:39 a.m. EDT Loading Chart for SLXN ...

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

Fortis stock opened at C$64.55 on Friday. Fortis has a 52 week low of C$51.02 and a 52 week high of C$65.26. The firm has a market cap of C$31.93 billion, a P/E ratio of 19.16, a P/E/G ratio of 3. ...

Exelixis, Inc announced that the U.S. Food and Drug Administration (FDA) has approved CABOMETYX® (cabozantinib) for the treatment of 1) adult and pediatric patients 12 years of age and older with ...

After hours: March 26 at 5:56:34 PM EDT Loading Chart for SNGX ...

After hours: March 26 at 7:56:54 p.m. EDT Loading Chart for CERO ...

After hours: 26 March at 6:15:12 pm GMT-4 Loading Chart for PHIO ...